Current strategies to treat chronic wounds offer limited relief to the 7.75 million patients who suffer from burns or chronic skin ulcers. Thus, as long as chronic wounds remain a global healthcare problem, the development of alternate treatments remain desperately needed. This review explores the recent strategies employed to tailor electrospun nanofiber mats towards accelerating the wound healing process. Porous nanofiber mats readily produced by the electrospinning process offer a promising solution to the management of wounds. The matrix chemistry, surface functionality, and mat degradation rate all can be fine-tuned to govern the interactions that occur at the materials-biology interface. In this review, first we briefly discuss the wound healing process and then highlight recent advances in drug release, biologics encapsulation, and antibacterial activity that have been demonstrated via electrospinning. While this versatile biomaterial has shown much progress, commercializing nanofiber mats that fully address the needs of an individual patient remains an ambitious challenge.
Introduction
Chronic wounds are a global healthcare problem. In the United States alone, 1.25 million patients suffer from burns and an additional 6.5 million patients endure chronic skin ulcers most commonly caused by pressure, venous stasis, or diabetes mellitus. In 2011, the CDC estimated that 25.8 million people-8.3% of the U.S. population-suffer from diabetes.
1 An estimated 15% of people with diabetes mellitus will develop lower extremity ulcers and up to one fourth of diabetic patients with foot ulcers will eventually undergo amputation. Annually in the U.S., approximately 100 000 lower extremity amputations are performed on diabetic patients.
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Though the two most common treatment options for chronic ulcers are potentially successful, neither ensures recovery. The rst option, negative pressure wound therapy, only effectively treats very small chronic wounds, while the second, hyperbaric Katrina A. Rieger is a Ph.D. candidate in Chemical Engineering at the University of Massachusetts Amherst where her current research focuses on designing and electrospinning novel bactericidal nanober mats composed of natural agents, such as chitosan, from crab shells, and cinnamaldehyde, from cinnamon bark. Advanced antibacterial coatings offer an environmentally friendly approach to preventing the spread of infectious diseases. She was one of nine recipients nationally to receive an Eli Lilly Travel Award and has been awarded an NSF-IGERT fellowship in Cellular Engineering. Rieger bioabsorbable polymer, patient comfort can be increased because the need to change the bandage is reduced. 6 By incorporating therapeutic or antimicrobial agents, functionalized electrospun mats could potentially serve as a personalized bandage that will contour to virtually any wound surface. 7 In this applications review, we present the ve stages of wound healing, the electrospinning process, and strategies towards engineering electrospun nanober mats into advanced nanobiomaterials.
Wound healing process
Naturally, when the skin is damaged, the body responds via a complex process known as wound healing. 8 Recent literature and numerous review articles provide detailed accounts of the wound healing process. [9] [10] [11] [12] [13] Therefore, in the following sections, we aim to present only the quintessential elements of (Section 2.1) how to categorize wounds and (Section 2.2) the stages of the wound healing process.
Categorizing wounds
Wounds-acute versus chronic-can be primarily categorized by their healing time. A wound that heals normally is an acute wound, while a wound that is arrested in a phase of healing is known as a chronic wound. Most oen, chronic wounds are arrested in the inammatory phase; high levels of matrix metalloproteinases (MMPs) cause degradation of the extracellular matrix (ECM) and of certain growth factors. The lengthened healing process associated with chronic wounds can cause a number of cells, particularly broblasts, present in the wound to become less active due to senescence (aging).
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The type of wound-cut versus burn-also affects the natural response of the body. Aer a cutting injury, hemostasis is achieved quickly, within the rst 15 minutes. 11 In contrast, when an injury is caused by a burn, wounding can continue for up to 4 days aer the initial trauma. The prolonged injury period, along with the increased extent of damage, causes a heightened inammatory response commonly leading to extensive and sometimes hypertrophic scarring. 12 
Five stages of wound healing
During the ideal healing process, the wound progresses through (i) wounding, (ii) hemostasis, (iii) inammation, (iv) proliferation, and nally (v) maturation (Fig. 2) . These phases may overlap in some instances, not all phases will be reached in chronic wounds.
The wounding phase ( Fig. 2A ) marks the beginning of the wound healing process. During this phase, the skin is punctured leaving dead and devitalized tissue. 8 Immediately, uid begins to leak from blood and lymphatic vessels, lling the injured site. Bacteria start to invade the open wound.
Within 15 minutes, local hemostasis is achieved at the wound site, (Fig. 2B) .
11 Injured blood and lymphatic vessels rapidly undergo vasoconstriction, 10 preventing blood ow into local tissue indicated by visible blanching.
11 Thrombocytes Fig. 1 Over the past dozen years, the number of electrospinning publications exhibit an upward trend. Plotted is the growth of publications on nanofibers electrospun (A) for any application and (B) specifically to address the topic of this review: wound healing or antibacterial activity. The SciFinder Scholar database was used to determine the total number of unique results from searching (A) "electrospinning" and (B) "electrospinning" plus "wound healing" or "antibacterial". The total counts is displayed above each bar; data analysis was conducted on migrate to the wound site and bronectin is cleaved into brin. Platelets, brin, bronectin, vitronectin, thrombospondin, and various blood cells 10 join to form a clot. In later wound healing stages, the clot serves as a provisional ECM for cell migration.
11
Fig. 2C displays the inammation phase, which follows hemostasis and can last for up to 6 days aer the wounding incident.
11 Vasodilation, accompanied by an increase in capillary permeability, is induced by chemical signals released from injured tissue and mast cells.
10 Polymorphonuclear cells, are the rst inammatory cells to arrive at the wound site; these cells are responsible for producing growth factors and removing cellular debris, foreign particles, and bacteria.
9,11
Monocytes migrate to the wound site, where they transform into macrophages 11 to remove necrotic tissue and foreign particles. 9 Macrophages also stimulate broblasts to produce collagen and inuence reepithelialization. The macrophage population reaches a peak 4 to 5 days aer wounding and remain at the site for multiple weeks.
11 Lymphocytes, particularly CD4 + , CD8 + , and dendritic gd epidermal T cells (DETCs), arrive approximately 6 days aer injury 10 to facilitate later stages of the wound healing process.
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The proliferation phase, Fig. 2D , is characterized by reepithelialization, which occurs 24-48 hours aer wounding. Keratinocytes migrate from the surrounding tissue and nearby hair bulges to the wound boundary. A wedge of keratinocytes, moving in from the edges across the wound, releases enzymes to begin the degradation of the provisional ECM. 11 The wedge continues until it contacts another wedge, leaving a stratied layer of keratinocytes in its wake. This migration is partially stimulated by the contact the cell has with brin and might also be motivated by connexins.
11 Keratinocyte migration does not depend on the number of platelets present but is slowed by the presence of neutrophils and macrophages, especially in diabetic wounds. During the second day of healing, endothelial cells begin migrating into the wound as part of angiogenesis-the physiological process wherein new blood vessels develop from preexisting vessels. The migration is driven by cytokines, the presence of an ECM, and the absence of neighboring endothelial cells. MMPs stimulate the degradation of the basement membrane and the ECM. The endothelial cells migrate through the ECM, form tubules, and eventually form new capillaries. Laminin production is stimulated in endothelial cells to produce a new basement membrane.
Approximately 4 days into the wound healing process, collagen-based granulation tissue replaces the brin-based provisional ECM. Granulation tissue contains broblasts, collagen, blood vessels, and macrophages and is similar to healthy ECM, except for the absence of elastin. In response to bronectin, cytokines, and growth factors, the broblasts migrate along the bronectin into the provisional ECM from the surrounding tissue. In addition to the existing broblasts, new broblasts are produced in response to macrophage products from nearby mesenchymal cells. All broblasts present in the provisional ECM regulate the growth and function of other cells within the matrix.
11 T cells, specically DETCs, stimulate broblasts to produce type I collagen, bronectin, and a5 integrin. 11 The net collagen deposition is needed to form the granulation tissue from 3 to 21 days aer wounding.
As new granulation tissue is being generated, the wound undergoes contraction, 4-14 days aer wound formation. Wound closure tends to occur at a rate of 0.6 to 0.75 mm per day and is aided by DETCs.
9 Approximately 4 to 6 days aer wounding, some broblasts are converted into myobroblasts, which produce actin and decrease wound closure time.
In the maturation phase, tissue remodeling begins with the replacement of granulation tissue with scar tissue approximately 3 to 6 weeks aer the wound incident and can continue for months, Fig. 2E . 11 Over time, the proportion of type I collagen increases, while the proportions of type III collagen, proteoglycans, and water decreases. During remodeling, collagen brils increase in diameter, exhibit increased inter-bril binding, and rearrange.
11 Mast cells may be involved in the collagen remodeling process as well. 9 In early phases of wound healing, collagen brils are arranged haphazardly, which results in a high level of collagen, and low relative tissue strength. Collagen brils become signicantly more ordered aer one year of recovery. As the scar matures, redness decreases as the capillary density decreases. The level of scar tissue is greatly inuenced by the presence of immune cells and the level of inammation that the wound has undergone. For example, the lack of immune cells has been linked to an absence of scar formation, as well as, a lower level of brogenic growth factor and a higher level of hyaluronic acid.
9 Scar formation increases in the presence of neutrophils, macrophages, and T cells, 9,14 while a large number of mast cells causes hypertrophic scarring. 
Commercial treatments versus electrospun nanofiber mats
Armed with the knowledge that the wound healing process is complex, it should come as no surprise that currently, no single treatment modality can address all aspects of the healing process. Hence, a plethora of options are available. As far as we are aware, clinical "head-to-head" trials between commercial treatments and electrospun nanober mats have not yet been conducted. However, the unique structure-to-function relationship of nanober mats can be discussed with regard to the properties offered by conventional treatment options. While in Sections 4 and 5 of this review we will discuss the specics of electrospun materials, here, we briey discuss why nanober mats hold promise as a commercially viable alternative to the current strategies.
Plain gauze is the most widely used material because it is inexpensive and readily available. However, it has numerous shortcomings, which have inspired the development of other approaches: foams, hydrogels, lms, biologic dressings, and hydrocolloids.
15 Conventional foams and hydrogel dressings can adsorb only minimal exudates with moderate success 15 and lack the additional features of more advanced dressings. 16 For instance, the nanostructure of an electrospun ber mat allows for an incredibly high surface area, better gas transport, and more efficient exudate absorption than traditional lms and foams.
5
Current biologic dressings fall into one of three categories: composite gras with epidermal and dermal components, dermal replacements, and epidermal gras. However, they all suffer from the major disadvantages of cost and availability.
19
On the other hand, recent advances have made electrospun materials commercially viable for some applications.
20
Traditional antibacterial ointments have to be reapplied oen to maintain moisture. 15 But, by properly choosing the electrospinning technique and post-processing steps, a prolonged and improved release prole of antibacterial agents can be achieved. Additionally, the frequency of dressing change could be lowered.
5,16
To date, no commercial strategy has replicated the complex biological functionality and biophysical properties offered by the native ECM. However, nanotopology has been noted as key determinant of cell proliferation and migration. 4, 18 Due to the morphology of ber mats fabricated by the electrospinning process, they are being proposed as a better ECM analog than current technologies. 4, 5, 17 Thus, unsurprisingly, electrospun nanober mats have been demonstrated to support the adhesion, proliferation, and differentiation of various cells. Additionally, they have served as a delivery platform for drugs, growth factors and other biomolecules that may further improve cell function and tissue regeneration. In order to match the innate structural advantages of electrospun ber mats, traditional wound dressings would have to undergo extensive lithography or imprinting. In terms of transport and materials availability, nanober mats can be spun directly onto the open wound of a patient. 21 In sum, the advantages that nanober mats have to offer, i.e., structural, functional, falling cost, and ease of use, add more incentive to fully explore their potential as wound healing scaffolds.
Electrospinning
Early exploration into electrodynamics laid the foundation to our current mechanistic understanding of the electrospinning process. Gilbert (1500s) reported that in the presence of charged amber, spherical droplets of water could be pulled into a conical shape. 22 Three hundred years later, the excitation of a dielectric liquid by an electric eld was reported by Lamor. 23 Signicant progress was documented in patents published in 1902 24,25 and 1934. [26] [27] [28] Electric elds were applied to polymer solutions using a systems approach featuring multiple spinnerets, a moving collection target, and a collector composed of parallel electrodes. These systems pioneered the design resembling modern laboratory and industrial electrospinning set-ups. While there have been numerous signicant lulls in electrospinning research over the past ve hundred years, current interest in this inexpensive nano-and macro-ber fabrication technique continues to be on the rise. 
Electrospinning process
A conventional electrospinning apparatus includes a high voltage power supply, a grounded collector, and a spinneret, Fig. 3 . Electrodes connect the collector to the spinneret, which completes a circuit to produce an electric eld. A precursor solution-typically a polymer, sol-gel, or melt-is loaded into the spinneret and advanced at a low feed rate allowing for the formation of a pendent drop held at the tip of the spinneret via surface tension. As the voltage is increased, the repulsive electrical forces pull the pendent drop into a conical shape known as a Taylor Cone. 30, 31 Once the voltage reaches a critical value, the electrical forces overcome the surface tension forces and a liquid jet emerges from the Taylor Cone, which reaches the collector in 18 nanoseconds. 32 During travel, the polymeric solution enters a bending instability where the liquid jet is stretched and whipped forcing the solvent to evaporate before bers are collected on the target. A polymer solution with an insufficient viscosity will experience an additional instability during travel known as the Rayleigh instability, which can cause inconsistent ber morphology, i.e., beading. Fig. 3 (A) The schematic displays an electrospinning apparatus, which is composed of a spinneret, a high voltage supply, and a collector. Usually, an advancement pump is used to regulate the flow rate of the polymeric solution. (B) The scanning electron micrograph displays the nanofiber morphology present in an electrospun non-woven mat, a 300 nm marker is displayed.
Electrospinning variables
Fabrication of bers via electrospinning is dependent on the precursor solution, processing variables, and ambient conditions. The extent of chain entanglement within a polymer solution is directly related to the ability to electrospin bers. Only once the polymer concentration is above the critical concentration, can ber spinning ensue. [33] [34] [35] Other properties of the precursor solution-conductivity, surface tension, viscosity, and polymer concentration-can be optimized by appropriate polymer and solvent selection. Different solvents and salts can be used to adjust the conductivity and surface tension of the system.
Controlling particular electrospinning apparatus parameters directly inuences the resultant mean diameter and arrangement of the accumulated bers. An increase in voltage or a decrease in feed rate will facilitate a reduction in ber diameter. 36 The separation distance needs to be sufficient for solvent evaporation but close enough to enable the desired brous morphology.
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Ambient parameters-temperature and humidity-should be controlled and monitored through the process since they affect ber formation. For example, an increase in temperature will decrease the average ber diameter, due to a decrease in solution viscosity. While an increase in humidity will increase the average ber diameter due to polymer swelling. [38] [39] [40] Fiber alignment can be achieved through the manipulation of the electric eld prole and appropriate collector selection. 41 Rotating drums, 42 parallel electrodes, 43 and an array of counter-electrodes 44 are example collectors, which have been implemented to generate a controlled arrangement of bers.
Nanofiber mats for wound healing
Electrospinning enables the fabrication of scaffolds, which can be easily altered in situ-during the electrospinning process-or post-fabrication to be suitable for a specic biomedical application. The rate at which drug(s) are released from a mat can be controlled through polymer selection, which dictates the degradation rate of the mat 45 or via the placement of the drug within, or on the surface of the bers. 46 Details concerning polymer selection, as well as numerous methods towards tailoring the location of the active agent within the electrospun mat are provided.
Polymer selection enables appropriate wound healing
When engineering mats for wound healing applications the appropriate polymer matrix, natural, synthetic, or a rational combination of polymers, should be selected that match the desired scaffold properties.
47 Natural polymers are derived from renewable sources and are intrinsically biocompatible and biodegradable. Polysaccharides, such as chitosan, [60] [61] [62] [63] have been electrospun for localized drug delivery. 47 Many of these polymers have specic properties that promote wound healing. For instance, chitosan exhibits both antibacterial and hemostatic activity. Synthetic polymers commonly used for wound healing applications include poly(ethylene oxide) (PEO), [64] [65] [66] poly(lactide) (PLA), [67] [68] [69] [70] [71] poly(caprolactone) (PCL), 72 and poly(vinyl alcohol) (PVA).
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Mats composed of these polymers display higher mechanical properties than natural polymers. Additionally, synthetic polymers are compatible with a wider range of solvents, which can facilitate the spinning process. 74 Oen, wound healing scaffolds depend on spinning the biopolymers in conjunction with a synthetic polymer in order to ne-tune the mechanical, degradation, and/or morphological features of the porous ber mats towards the needs of the individual patient.
Electrospinning technique tailors the active agent location
Strategically designed electrospun mats are enabled by implementing a variety of electrospinning and post-processing techniques. Depending on the desired release rate, active agents can be incorporated within or decorated on the outside of the bers, Fig. 4 . Implementing solution blending or core/shell electrospinning can additionally provide active agents that are housed inside the bers. Typically, modication of nanober mats aer electrospinning yields bers with the active agents close-to or on the outer surface of the bers.
5.2.1 Blend electrospinning yields a dispersed active agent. Blending, 75 consists of suspending a drug, 76 an active agent, 77 or a precursor agent (e.g., silver ions 78 ) that can be reduced to an active agent (e.g., silver nanoparticles) into the electrospinning solution, Fig. 4A . The as-spun mats can contain the agent dispersed throughout or at the surface 79,5 of the bers. This technique requires the traditional electrospinning apparatus and can be used to incorporate a multitude of polymers and wound treating agents. 80 Ojha et al. 65 demonstrated that polymer/agent blend bers can accumulate the agent along the surface of the bers, which occurs in situ as the solvent is being evaporated. As a result, these blended bers exhibit a high initial release of drug known as a burst release. 81 Non-steroidal anti-inammatory drugs (NSAIDs) are a group of agents where a burst release would be favorable. A PLGA electrospun mat containing ibuprofen was shown to reduce pain immediately and prevent the response of broblasts to major pro-inammatory stimulators due to a burst release of medicine characteristic of polymer/agent blend bers.
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A high initial release of an antibiotic is desirable at the site of a wound to eliminate bacteria, while a subsequent slow release of drug aids in preventing an infection. Jannesari et al. 73 electrospun composite PVA/poly(vinyl acetate) (PVAc) nanober mats containing ciprooxacin HCl, whose initial burst release rate was doubled when the drug content was increased from 5 to 10 weight percent (wt%). By blending the hydrophobic polymer, PVAc, into the bers, the hydrophilic model drug would be more likely to migrate to the surface of the bers during solvent evaporation. Additionally, the PVAc mats were better engineered for wound healing because they demonstrated a slower sustained release rate and were more exible.
Coaxial electrospinning controls active agent release.
When a burst release is not desired or the bioactivity of the agent is sensitive to harsh solvents, encasing the agent in a polymeric shell is necessary. Coaxial electrospinning [82] [83] [84] [85] [86] produces core/shell bers by using a "coaxial" or concentric needle arrangement, which features an inner and an outer channel to separate two or more solutions, Fig. 4B . In the context of synthesizing wound healing mats, an outer polymer shell can be used to encase the active agent. To do this, the active agent is fed through the inner channel. The outer shell provides a protective barrier from the electric eld, as well as from harsh solvents, which might be needed to electrospin the polymer located in the outer channel of the syringe. 87 Additionally, non-spinnable material such as inorganic nanomaterials can be electrospun into the core of the ber by placing a polymer in the outer channel to carry the non-viscous material through the process.
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While the addition of an inner channel increases the processing parameters that need to be optimized, this electrospinning technique is superior for obtaining controlled drug release via eliminating a burst release. Su et al. 89 compared the release rates of heparin encapsulated in the core of poly(L-lactide-co-3-caprolactone) (PLCL) bers and bers composed of heparin blended with PLCL. The composite bers showed a high initial release while heparin, once located in the core of the ber, demonstrated a stable sustained release over two weeks. It was deduced that the release from the core/shell bers was governed by a coupled diffusion/degradation mechanism.
5.2.3 Emulsion electrospinning enables active agent loading. Another route towards achieving a core/shell morphology is to employ an emulsion as the precursor solution, [90] [91] [92] [93] [94] Fig. 4C . Here, a surfactant is used to separate the distinct phases. This type of electrospinning allows for the incorporation of protein, DNA, and peptides by preventing their exposure to harsh organic solvents. 94 Yang et al. 93 demonstrated the use of emulsion electrospinning as a carrier for therapeutic proteins via electrospinning an emulsion consisting of a water phase containing the model protein, bovine serum albumin, and an organic phase using the polymer, poly(DL-lactide). In addition to keeping the encapsulated protein bioactive, the initial burst could be reduced through lowering the volume ratio of aqueous to organic phase.
Water-in-oil (W/O) emulsions have been electrospun wherein the oily phase consists of a polymer dissolved in an organic solvent and the water phase contains the active agent. This system is ideal for the delivery of a hydrophilic drug because a hydrophobic shell is needed to protect the drug from dissolving instantaneously in the blood stream. 92 For example, by spinning from an emulsion pre-curser solution, TCH (a hydrophilic antibiotic) was successfully encapsulated within the core of poly(ethylene glycol) PEG-PLA nanobers. 95 As characteristic of emulsion electrospinning, these bers showed a stable release rate, elimination of an initial burst release, and protection of the active agent incorporated.
Post-processing of electrospun mats enhances wound healing properties
The surface of an electrospun mat might lack the properties needed for a specic bio-application. As a result, as-spun bers can be modied post-spinning via electrostatic attachment, C. 97 In addition to using this facile process, another advantage of coating is that chemically, the chitosan coating more closely resembled glycosaminoglycans in the ECM than their control (chitosan-PVA blend bers). In order to provide immediate hemostatic activity, Spasova et al. 98 also chose chitosan to coat their wound healing electrospun PLA and PLA-PEG mats.
Performing chemical modications to functional groups located on the surface of the bers can enable the attachment of biofunctional molecules or tune the degree of hydrophilicity of the mat. The addition of a biofunctional molecule can promote certain biological activities such as cell proliferation and migration.
101 This is specically important in treating diabetic ulcers, where the natural wound healing process is compromised, thus leading to chronic wounds and in some cases amputation. EGF, the epidermal growth factor, was chemically immobilized to functional amine groups on the surface of PCL and PCL-PEG block copolymer blended bers to treat diabetic ulcers. 102 In vivo wound studies demonstrated an increase of keratinocyte-specic genes as a result of the EGF conjugated bers. Thus, the incorporation of a growth factor facilitated gene expression, which in turn accelerated wound healing.
Through the attachment of biomolecules onto the surface of bers, the mat can be functionalized to make use of the body's natural enzymes. A MMP-responsive release dressing was electrospun as a local gene delivery system to treat diabetic ulcers, which display high levels of MMPs. 100 Linear polyethyleneimine (LPEI) was chemically attached through an MMP-cleavable peptide linkage to amine groups, which were already present on the surface of PCL-PEG nanobers. The mat was further modied through the electrostatic attachment of negatively charged DNA to the positively charged LPEI. The ability to release DNA in the presence of MMP makes this system ideal for local gene therapy of diabetic ulcers.
Antibacterial nanober mats can reduce chronic wound biolms
Prevention of an infection is essential to complete wound repair. The addition of antibacterial agents-inorganic, organic, or metallic-into electrospun mats has continually been an important research focus (Fig. 1) , especially as antibiotic resistant bacteria strains increasingly emerge. A wide range of biocidal nanobers is imperative to effectively treat both the Gram-positive and the Gram-negative bacteria present during wound healing and for the prevention of hospital-acquired infections.
Metals have been incorporated into electrospun mats as antibacterial agents; the most common of these agents is silver. 51, 78, 79, 96, 103 Silver displays a wide spectrum of biocidal activity and a low bacterial resistance as compared to other antimicrobials agents. In wound healing, silver decreases surface inammation and promotes surface calcium, stimulating epithelialization. In order for silver to be incorporated, a reducing method must be utilized to prevent cytotoxicity. This can be achieved by using an aqueous route instead of an organic agent. 103 Nguyen et al. 79 took advantage of the ability of PVA to be a reducing agent for silver nanoparticles/PVA blended bers. Once electrospun, a heat treatment process was employed to draw silver nanoparticles to the surface of the bers where they can be the most effective. The use of PVA as a reducing agent allowed for a faster, simpler and more economical process than conventional methods. Silver has additionally been reduced in situ while electrospinning a number of other polymer mats.
104,105
The bactericidal efficacy of silver nanoparticle (AgNP)-coated electrospun ber mats has been demonstrated for the rst time by Schiffman et al. 96 Here, polysulfone (PSf) ber mats were electrospun and then surface-modied using an oxygen plasma treatment, which allowed for the facile irreversible deposition of cationically charged polyethyleneimine (PEI)-AgNPs via electrostatic interactions. Time-dependent bacterial cytotoxicity studies indicate that the optimized PSf-AgNP mats exhibit a high level of inactivation against both Gram-negative bacteria, Escherichia coli (E. coli), and Gram-positive bacteria, Bacillus anthracis (B. anthracis) and Staphylococcus aureus (S. aureus). Although silver, like many other metals, displays excellent antibacterial properties, it can also cause irritation and bind to DNA preventing replication, both of which can hinder the healing process.
Inorganic materials, specically titania, have been incorporated within electrospun bandages. Pure and iron (Fe)-doped titania nanobers, spun from ceramic-polymer precursor solutions, demonstrated photoactivated antimicrobial activity against E. coli using multiphoton infrared spectroscopy for 3 seconds.
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Titania also exhibited antibacterial efficiency against Pseudomonas aeruginosa (P. aeruginosa) and S. aureus when loaded into polyurethane (PU) electrospun bers.
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Testing performed in solution on titania mats doped with 0.4 and 1.6 mg mL À1 of zinc (Zn) 108 demonstrated an inhibition of E. coli and S. aureus growth, respectively.
Carbon-based nanomaterials are cytotoxic to bacteria.
109-111
Of this class of materials, single-walled carbon nanotubes (SWNTs) exhibit the highest toxicity and they can kill microbes on contact. 112, 113 For the rst time, Schiffman et al. 75 has demonstrated that even at a low weight percent loading of incorporated SWNTs, their antibacterial activity is retained. Four different weight percents of well-characterized, small diameter (0.8 nm) SWNTs were incorporated into electrospun polysulfone (PSf) mats. Electrospun PSf-SWNT mats were observed to be exible and composed of continuous, cylindrical, and randomly oriented bers. Loss of bacteria (E. coli) viability was observed to directly correlate to increased SWNT incorporation within the mat, ranging from 18% for 0.1 wt% SWNTs to 76% for 1.0 wt% SWNTs. Time-dependent bacterial cytotoxicity studies indicated that the antimicrobial action of the PSf-SWNT mats occurs aer a short contact time of 15 minutes or less.
Alternatively, researchers have been inspired by nature for antibacterial agents. Plant-based antimicrobials, shikonin and alkannin, loaded into polymeric bers demonstrated biocidal activity against both S. aureus and E. coli. The ber mats additionally provided aid in both the inammation and proliferative phases of wound healing. 114, 115 Fusidic acid, a protein synthesis inhibitor derived from fungus, was blended into PLGA bers to prevent the growth of bacteria. 69 The drug release from these bers was dependent on the severity of the wound. Both lightly and heavily infected wounds were treated via bioburden-triggered drug release of fusidic acid from PLGA mats. Lysostaphin (Lst), a cell lytic enzyme with specic bactericidal activity against S. aureus, was immobilized on the surface of cellulose, cellulose/ chitosan, and cellulose/poly(methyl methacrylate) (PMMA) electrospun ber mats. 116 In addition to cleaving the pentaglycine cross-bridges in the peptidoglycan layer of the cell walls of S. aureus, Lst loaded nanobers also displayed low toxicity towards keratinocytes, which are cells imperative in the proliferative phase of wound healing. Motivated by the ndings by Zodrow et al.,
117 cinnamaldehyde (CA), an essential oil derived from cinnamon bark, was delivered from electrospun nanober mats. A Schiff base reaction was employed to reversibly conjugate CA (0.5 and 5.0%) to chitosan. Chitosan and chitosan-CA derivatives were electrospun with PEO into nanober mats, all of which had an average ber diameter of~50 nm. At physiological conditions the Schiff base was reversed, thus releasing CA-liquid and CA-vapor from the chitosan-CA nanober mats. CA release was correlated to time-dependent bacterial cytotoxicity against two Gram-negative bacteria, E. coli and P. aeruginosa. Fig. 6 displays that due to their chitosan content alone, aer 180 minutes of incubation, the control mats inactivated 47 AE 4.4% P. aeruginosa. However, by statistically increasing the availability of the CA to interact with the bacteria, the antibacterial activity of the mats increased. A very high inactivation against this opportunistic human pathogen, 81 AE 4.1%, was achieved by the nanober mats, which were spun with the 5.0 wt% chitosan-CA derivative. Their ndings indicate that potentially chitosan-CA nanober mats could serve as therapeutic wound dressings to treat nosocomial pseudomonas infections.
Emerging nanober mats that strategically target multiple facets of wound healing
The next generation of electrospun mats will be functionalized to fulll multiple components of the wound healing process. The current aim is to develop systems that not only target various components of the wound healing process (i.e., anti-inamma-tory and antibacterial activity) but also provide an adjustable and controlled release of multiple drugs. 119 The amount and progression (be that simultaneous or a stepwise release) of drugs will be determined by the stage of the healing wound.
Fibers with a core/shell structure offer a simple way to deliver more than one active agent. Using coaxial electrospinning, Su et al. 46 fabricated core/shell poly(L-lactide-co-caprolactone) (PLLACL) bers to encapsulate both rhodamine B (RHB) and bovine serum albumin (BSA). To study the effect of drug placement on release rates, three different systems were fabricated: (i) two drugs in the shell, (ii) two drugs in the core, and (iii) one drug in the shell and one in the core. The drug encapsulated within the core displayed a slow release rate, unlike the burst release exhibited when the drug was placed in the shell. Certainly, the core/shell thickness ratio can be adjusted to tailor release rates.
Core/shell morphology is also favored when fabricating multifunctional bers because the encapsulated agent is protected from post-spinning functionalization. To treat diabetic ulcers, Choi et al. 82 electrospun core/shell basic broblast growth factor (bFGF)/PCL-PEG block copolymer bers using a coaxial apparatus. EGF was conjugated to the exposed amine groups on the surface of the bers, thus further functionalizing them. The nanober mats demonstrated biphasic release proles, which supplied a cascade of growth factors to increase collagen and keratin expression leading to a decreased healing time.
Recently, triaxial electrospinning of nanober has been demonstrated in an effort to improve the biocompatibility, mechanical properties, and the incorporation of drugs into mats for biomedical application. By using three concentric needles, Lui et al. 120 have electrospun biodegradable nanobers, which have an outer and inner gelatin layer, as well as a middle layer composed of PCL. Most core/shell morphology nanobers can only meet one or two of these objectives, showing advantages for a three-layer structure.
Spinning two types of polymer bers, each containing an active agent, onto the same collector, is another approach to develop multi-component mats. Simultaneously, two solutions of poly(L-lactic acid) (PLLA) were spun using separate spinnerets, which were connected to the same target to fabricate a wound healing bandage. 71 One solution contained lidocaine, an anesthetic, while the other carried the antibiotic mupirocin. The resulting mats demonstrated altered kinetics when compared to electrospun mats containing only one of the active agents. Lidocaine shows a higher burst release, while mupirocin shows a sustained release rate.
Encapsulation of an active agent in micro/nanoparticles, which were then electrospun, has been proposed as an effective means to produce multifunctional bers. PLLA/polyvinylpyrrolidone (PVP) blended bers were used to encapsulate the model hydrophilic and hydrophobic drugs, bovine serum albumin (BSA) and benzoin, respectively. This was accomplished by loading BSA into chitosan microspheres, which were then suspended into the polymer solution along with benzoin.
121 By loading one drug into microspheres, each agent had distinct release rates that could be adjusted by changing the polymer blend ratio. Song et al. 122 also investigated the use of particles to encapsulate an active agent. RHB was enveloped inside mesoporous silica nanoparticles (MSNs) and incorporated into a PLGA/uorescein (FLU) polymer/drug blended solution. The release rates were found to be independent of each other, which is in agreement with the previous example. The loading percent of MSNs was directly related to the release of RHB and even at high loading levels, RHB was released at a slow sustained rate.
Perspective
In the quest to develop an ideal wound healing dressing, there exists a consensus that the material should be antibacterial, Fig. 6 Recently, Rieger and Schiffman 118 blend electrospun chitosan/polyethylene oxide (PEO) nanofiber mats (control), as well as PEO blended with two synthesized chitosan-cinnamaldehyde (CA) derivatives (0.5% and 5.0% CA). CA release was correlated to time-dependent bacterial cytotoxicity against two Gram negative bacteria, Escherichia coli and Pseudomonas aeruginosa (shown above). Asterisks (**) denote that a statistical increase in cytotoxicity occurred whereas "NS" indicate that the change is not significant. Figure from ref. 118. nontoxic to mammalian cells, nonantigenic, permeable for gaseous exchange, and resistant to shearing forces; while also being elastic and exible to conform well to the underlying topography. From the perspective of the patient, other essential properties for a dressing include reducing pain and healing time, as well as increased long-term aesthetics. To ensure that commercialization is a success, the dressing should be inexpensive and have a long shelf life.
123,124
However, due to the complexity of the healing process no panacea exists. In part because different wounds have different needs from a wound dressing. Heavily exuding wounds require an exceptionally absorbent dressing, while a dry wound should receive a high water content dressing for rehydration. Nanober mats electrospun from biopolyelectrolytes, such as hyaluronic acid 56 hold promise for these wounds. A cavity wound must be packed with a exible and suitable dressing.
13 Nanober mats can be directly spun as a conformal coating onto practically any surface, thus, a good option for cavity wounds.
5,21 If a wound is contaminated with bacteria, as is the case for diabetic foot, pressure, and venous leg ulcers, then the bandage needs to be able to disrupt the biolm.
2 Section 5.4 discusses numerous case studies where antimicrobial nanober mats have delayed the onset of biolm formation, however future research aimed to inactivate specic microbes would further these wound dressings for individualized health care.
As a value-added product, wound healing scaffolds do not require the same economics of scale needed for many other industries. While electrospun materials are commercially viable for some applications, 20 increasing the production of bioactive electrospun nanober mats beyond the bench scale still remains an obstacle. However, this is not unique to nanostructured dressings as commercially available dressings are also currently expensive and limited.
19
Without a doubt, signicant advances over the past dozen years have been made to tailor nanober mats towards wound healing applications. However, there are numerous additional factors-clinical, psychosocial, educational, and professional/ organizational-that may also delay the clinical implementation of nanober mats.
125
Most relevant to this review is the need for the scientists and engineers who designed the nanostructured wound dressings to work with clinicians to increase educational best practices. For example, if a nanober mat is engineered to stay on a cavity wound for a longer duration of time than the current commercial treatment, this procedure must be well communicated to the clinician to ensure that when the randomized controlled trials (RCTs) are conducted, there will be an improved interpretation of results. Well-designed RCTs are the "gold standard" method of evaluating effectiveness of a wound dressing 125 and still remain essential before the commercialization of highly specied electrospun nanober mats tailored for wound healing.
Conclusions
The continued development of antimicrobial resistance, globalization, and industrialization reinforces the need to engineer alternate treatments, which can successfully heal chronic wounds. Scaffolds composed of electrospun nanobers have demonstrated an impressive versatility. Matrix chemistry, surface functionality, and mat degradation rate can be tuned in conjunction to govern the interactions that occur at the interface between the materials' surface and biology. With the addition of more RCTs in clinical settings, tailored electrospun nanober mats can offer a broad impact to the nanomedicine community.
